PND19 COST—EFFECTIVENESS OF SUGAMMADEX IN THE MANAGEMENT OF PATIENTS WITH UNANTICIPATED DIFFICULT INTUBATION AND PATIENTS NEEDING RAPID SEQUENCE INTUBATION [PDF]
Aguilera, L+7 more
core +1 more source
New way of dosing sugammadex for termination of vecuronium induced neuromuscular block
Background and Goal of Study: Sugammadex is a selective binding agent that bindsaminosteroid muscle relaxants. Each molecule of sugammadex binds one molecule of musclerelaxant.
Blaž Peček, Damjan Polh, Tea Priman
doaj
Sugammadex and the cannot intubate/cannot ventilate scenario in patients with predicted difficult airway (1) Letter 1 [PDF]
Tiberiu Ezri, Shmuel Evron
openalex +1 more source
Sugammadex - A short review and clinical recommendations for the cardiac anesthesiologist
ThomasM Hemmerling+3 more
openalex +1 more source
Sugammadex: the sting in the tail? [PDF]
Sinisa Savic+4 more
openaire +3 more sources
Sugammadex-induced anaphylactic shock [PDF]
Ha-Jung Kim+4 more
openaire +4 more sources
PSY8 The Budget Impact of Qutenza® for the Treatment of Neuropathic Pain in Sweden [PDF]
Bentley, A.+3 more
core +1 more source
Sugammadex or neostigmine for reversal of neuromuscular block on the quality of postoperative recovery in elderly adults undergoing video-assisted thoracoscopic lobectomy: a randomised controlled trial. [PDF]
Yang Y+7 more
europepmc +1 more source